Monitoring and Managing Cardiovascular Risk in Immune Mediated Inflammatory Diseases

Panagiota Anyfanti1, Athanasia Dara2, Elena Angeloudi1

  • 1Second Medical Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Insights

Cardiovascular disease (CVD) is a major concern for patients with immune-mediated inflammatory diseases (IMIDs). This review explores strategies to manage CVD risk in IMIDs, highlighting lifestyle changes and medication awareness.

Area of Science:

  • Rheumatology
  • Cardiology
  • Inflammation

Background:

  • Cardiovascular disease (CVD) is highly prevalent in immune-mediated inflammatory diseases (IMIDs).
  • Chronic inflammation and traditional risk factors contribute to increased CVD morbidity and mortality in IMID patients.
  • Standard CVD risk calculators underestimate risk in IMID populations, necessitating tailored assessment.

Purpose of the Study:

  • To provide an overview of current and emerging strategies for CVD risk mitigation in patients with IMIDs.
  • To offer a practical approach for managing CVD risk in this vulnerable patient group.

Main Methods:

  • Review of current literature on CVD risk in IMIDs.
  • Discussion of challenges in CVD risk assessment for IMID patients.
  • Exploration of artificial intelligence applications in predictive medicine for CVD.

Main Results:

  • Traditional CVD risk calculators are inadequate for IMID patients.
  • Behavioral interventions targeting modifiable lifestyle factors are crucial.
  • Awareness of antirheumatic medication's impact on CVD risk is essential for rheumatologists.

Conclusions:

  • Effective CVD risk management in IMIDs requires a multi-faceted approach.
  • Personalized predictive medicine holds future promise but needs validation.
  • Integrating lifestyle interventions and careful medication management is key for improving outcomes.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
49
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
56
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
62
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
112
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
53